List of works - Monika Niewczas

A profile of multiple circulating tumor necrosis factor receptors associated with early progressive kidney decline in Type 1 Diabetes is similar to profiles in autoimmune disorders

scientific article published on 24 July 2020

A signature of circulating inflammatory proteins and development of end-stage renal disease in diabetes

scientific article published on 22 April 2019

Association between a genetic variant related to glutamic acid metabolism and coronary heart disease in individuals with type 2 diabetes

scientific article published on August 2013

Association of urinary inflammatory markers and renal decline in microalbuminuric type 1 diabetics

scientific article published on 6 February 2008

Between hyperfiltration and impairment: demystifying early renal functional changes in diabetic nephropathy.

scientific article published on 11 October 2008

Can existing drugs approved for other indications retard renal function decline in patients with type 1 diabetes and nephropathy?

scientific article published on September 2012

Characterization of Glycolytic Enzymes and Pyruvate Kinase M2 in Type 1 and 2 Diabetic Nephropathy

scientific article published on 10 May 2019

Characterization of human invariant natural killer T cells expressing FoxP3.

scientific article published on 27 June 2011

Circulating Modified Metabolites and a Risk of ESRD in Patients With Type 1 Diabetes and Chronic Kidney Disease.

scientific article published on 13 January 2017

Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes

scientific article published on 19 January 2012

Circulating TNF receptors 1 and 2 predict stage 3 CKD in type 1 diabetes

scientific article published on 19 January 2012

Circulating miRNA Profiles Associated With Hyperglycemia in Patients With Type 1 Diabetes Mellitus.

scientific article published on 16 February 2018

Circulating short and medium chain fatty acids are associated with normoalbuminuria in type 1 diabetes of long duration

scientific article published on 21 April 2021

Early progressive renal decline precedes the onset of microalbuminuria and its progression to macroalbuminuria.

scientific article published on 12 August 2013

Elevated urinary excretion of immunoglobulins in nonproteinuric patients with type 1 diabetes

scientific article

Elevation of circulating TNF receptors 1 and 2 increases the risk of end-stage renal disease in American Indians with type 2 diabetes.

scientific article

Genetic Variant at the GLUL Locus Predicts All-Cause Mortality in Patients With Type 2 Diabetes

scientific article published on 12 February 2015

High-normal serum uric acid increases risk of early progressive renal function loss in type 1 diabetes: results of a 6-year follow-up

scientific article

High-normal serum uric acid is associated with impaired glomerular filtration rate in nonproteinuric patients with type 1 diabetes.

scientific article published on 13 February 2008

IL 6 but not TNF is linked to coronary artery calcification in patients with chronic kidney disease

scientific article published on 13 April 2019

Improved clinical trial enrollment criterion to identify patients with diabetes at risk of end-stage renal disease

scientific article published on 07 April 2017

Increased plasma kidney injury molecule-1 suggests early progressive renal decline in non-proteinuric patients with type 1 diabetes.

scientific article published on 28 October 2015

Interleukin-10+ regulatory B cells arise within antigen-experienced CD40+ B cells to maintain tolerance to islet autoantigens

scientific article

Long-term heart transplant survival by targeting the ionotropic purinergic receptor P2X7

scientific article published on 18 December 2012

Markers of early progressive renal decline in type 2 diabetes suggest different implications for etiological studies and prognostic tests development.

scientific article published on 2 February 2018

Metabolomic Profiling in Individuals with a Failing Kidney Allograft

scientific article

Plasma kininogen and kininogen fragments are biomarkers of progressive renal decline in type 1 diabetes.

scientific article

Progressive renal decline as the major feature of diabetic nephropathy in type 1 diabetes

scientific article

Pyruvate kinase M2 activation may protect against the progression of diabetic glomerular pathology and mitochondrial dysfunction.

scientific article

Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-acetyl-β-D-glucosaminidase.

scientific article

Response to Comment on Niewczas et al. Circulating Modified Metabolites and a Risk of ESRD in Patients With Type 1 Diabetes and Chronic Kidney Disease. Diabetes Care 2017;40:383-390.

scientific article published in August 2017

Risk for ESRD in Type 1 Diabetes Remains High Despite Renoprotection ⬇️

scientific article published on February 25, 2011

Risk of ESRD and all cause mortality in type 2 diabetes according to circulating levels of FGF-23 and TNFR1.

scientific article

Role of podocyte B7-1 in diabetic nephropathy ⬇️

scientific article

Serum concentrations of markers of TNFalpha and Fas-mediated pathways and renal function in nonproteinuric patients with type 1 diabetes.

scientific article published on 10 December 2008

Serum levels of advanced glycation endproducts and other markers of protein damage in early diabetic nephropathy in type 1 diabetes

scientific article

Synergism between circulating tumor necrosis factor receptor 2 and HbA(1c) in determining renal decline during 5-18 years of follow-up in patients with type 1 diabetes and proteinuria.

scientific article

The early decline in renal function in patients with type 1 diabetes and proteinuria predicts the risk of end-stage renal disease ⬇️

scientific article published on May 23, 2012

Transcriptome analysis of proximal tubular cells (HK-2) exposed to urines of type 1 diabetes patients at risk of early progressive renal function decline

scientific article

Tumor necrosis factor receptors 1 and 2 are associated with early glomerular lesions in type 2 diabetes

scientific article published on 23 September 2015

Uremic solutes and risk of end-stage renal disease in type 2 diabetes: metabolomic study

scientific article

[Enzymatic activity of cathepsin B, cathepsin B and L, plasmin, trypsin and collagenase in hepatocellular carcinoma]

scientific article published on 01 July 2002

[Noninvasive monitoring of chronic glomerulonephritides progression]

scientific article published on 01 November 2002

List of works by Monika Niewczas

A profile of multiple circulating tumor necrosis factor receptors associated with early progressive kidney decline in Type 1 Diabetes is similar to profiles in autoimmune disorders

A signature of circulating inflammatory proteins and development of end-stage renal disease in diabetes

Association between a genetic variant related to glutamic acid metabolism and coronary heart disease in individuals with type 2 diabetes

Association of urinary inflammatory markers and renal decline in microalbuminuric type 1 diabetics

Between hyperfiltration and impairment: demystifying early renal functional changes in diabetic nephropathy.

Can existing drugs approved for other indications retard renal function decline in patients with type 1 diabetes and nephropathy?

Characterization of Glycolytic Enzymes and Pyruvate Kinase M2 in Type 1 and 2 Diabetic Nephropathy

Characterization of human invariant natural killer T cells expressing FoxP3.

Circulating Modified Metabolites and a Risk of ESRD in Patients With Type 1 Diabetes and Chronic Kidney Disease.

Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes

Circulating TNF receptors 1 and 2 predict stage 3 CKD in type 1 diabetes

Circulating miRNA Profiles Associated With Hyperglycemia in Patients With Type 1 Diabetes Mellitus.

Circulating short and medium chain fatty acids are associated with normoalbuminuria in type 1 diabetes of long duration

Early progressive renal decline precedes the onset of microalbuminuria and its progression to macroalbuminuria.

Elevated urinary excretion of immunoglobulins in nonproteinuric patients with type 1 diabetes

Elevation of circulating TNF receptors 1 and 2 increases the risk of end-stage renal disease in American Indians with type 2 diabetes.

Genetic Variant at the GLUL Locus Predicts All-Cause Mortality in Patients With Type 2 Diabetes

High-normal serum uric acid increases risk of early progressive renal function loss in type 1 diabetes: results of a 6-year follow-up

High-normal serum uric acid is associated with impaired glomerular filtration rate in nonproteinuric patients with type 1 diabetes.

IL 6 but not TNF is linked to coronary artery calcification in patients with chronic kidney disease

Improved clinical trial enrollment criterion to identify patients with diabetes at risk of end-stage renal disease

Increased plasma kidney injury molecule-1 suggests early progressive renal decline in non-proteinuric patients with type 1 diabetes.

Interleukin-10+ regulatory B cells arise within antigen-experienced CD40+ B cells to maintain tolerance to islet autoantigens

Long-term heart transplant survival by targeting the ionotropic purinergic receptor P2X7

Markers of early progressive renal decline in type 2 diabetes suggest different implications for etiological studies and prognostic tests development.

Metabolomic Profiling in Individuals with a Failing Kidney Allograft

Plasma kininogen and kininogen fragments are biomarkers of progressive renal decline in type 1 diabetes.

Progressive renal decline as the major feature of diabetic nephropathy in type 1 diabetes

Pyruvate kinase M2 activation may protect against the progression of diabetic glomerular pathology and mitochondrial dysfunction.

Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-acetyl-β-D-glucosaminidase.

Response to Comment on Niewczas et al. Circulating Modified Metabolites and a Risk of ESRD in Patients With Type 1 Diabetes and Chronic Kidney Disease. Diabetes Care 2017;40:383-390.

Risk for ESRD in Type 1 Diabetes Remains High Despite Renoprotection ⬇️

Risk of ESRD and all cause mortality in type 2 diabetes according to circulating levels of FGF-23 and TNFR1.

Role of podocyte B7-1 in diabetic nephropathy ⬇️

Serum concentrations of markers of TNFalpha and Fas-mediated pathways and renal function in nonproteinuric patients with type 1 diabetes.

Serum levels of advanced glycation endproducts and other markers of protein damage in early diabetic nephropathy in type 1 diabetes

Synergism between circulating tumor necrosis factor receptor 2 and HbA(1c) in determining renal decline during 5-18 years of follow-up in patients with type 1 diabetes and proteinuria.

The early decline in renal function in patients with type 1 diabetes and proteinuria predicts the risk of end-stage renal disease ⬇️

Transcriptome analysis of proximal tubular cells (HK-2) exposed to urines of type 1 diabetes patients at risk of early progressive renal function decline

Tumor necrosis factor receptors 1 and 2 are associated with early glomerular lesions in type 2 diabetes

Uremic solutes and risk of end-stage renal disease in type 2 diabetes: metabolomic study

[Enzymatic activity of cathepsin B, cathepsin B and L, plasmin, trypsin and collagenase in hepatocellular carcinoma]

[Noninvasive monitoring of chronic glomerulonephritides progression]